Trial intelligence / Profile preview

Effect of Metformin on Glioblastoma Multiforme

IRCT2015112725256N1Phase 2Completed

Sponsor
Neuroscience Research Center, Kerman University of Medical Sciences
Start
Jul 2016
Modality
Small Molecules
Countries
1
01

Overview

Phase 2 trial of metformin in glioblastoma (GBM), sponsored by Neuroscience Research Center, Kerman University of Medical Sciences. Started Jul 2016; status: completed.

02

Drugs

metformin
03

Conditions

glioblastoma (GBM)

Beyond the preview

Go deeper on IRCT2015112725256N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT2015112725256N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call